Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 225 of 6351
-
Could a vaccine stop recurrent UTIs? new trial underway
Vaccine Recruiting nowThe purpose of this study is to assess safety, reactogenicity, and immune response of the candidate UTI vaccine compared to placebo in adults between and including 18-64 years of age (YOA), and to perform a preliminary evaluation of clinical efficacy in females between and includ…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC
-
Can a biosimilar match prolia in strengthening bones?
Disease control CompletedThis study is a multicenter, randomized, double-blinded, parallel-group Phase III clinical study to compare the clinical efficacy, safety, and immunogenicity of 9MW0311 and Prolia® in Chinese postmenopausal women with osteoporosis at high risk for fracture.
Phase 3 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Supercharged immune cells aim to stop leukemia relapse after transplant
Disease control Recruiting nowThis trial represents a single institution phase I/II pilot study with the primary objective of establishing the safety and feasibility of generating and infusing ML NK cells after TCRαβ haplo-HCT.
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New pill could tame tough eczema without creams
Disease control Recruiting nowA randomized, double-blind, placebo-controlled phase III study evaluating the efficacy and safety of oral ICP-332 in subjects with moderate to severe atopic dermatitis
Phase 3 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:51 UTC
-
New weekly shot aims to stop liver disease from getting worse
Disease control Recruiting nowThis study is open to adults who are at least 18 years old and have: * A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or * A confirmed liver disease called metabolic-associated steatohepatitis (MASH) * BMI of 27 kg/m2 or more or * 25 kg/m2 or more if the p…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could early aspirin boost stroke recovery? new trial investigates
Disease control Recruiting nowStroke is the second leading cause of death worldwide, and ischemic stroke is the most frequent type. Intravenous thrombolysis with recombinant tissue plasminogen activator within 4.5 hours of symptom onset is the most effective therapy for patients with acute ischemic stroke. Ho…
Phase 3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can fish oil calm ADHD and autism symptoms? a new trial investigates
Symptom relief CompletedOur study aims to determine whether omega-3 fatty acid supplementation can improve sleep, mood, and behavior in children with sleep problems and symptoms of Autism Spectrum Disorder (ASD), Attention-Deficit/Hyperactivity Disorder (ADHD), or both. By using a transdiagnostic approa…
Sponsor: Swansea University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a new injection help tame type 2 diabetes?
Disease control CompletedThis study aims to confirm that SHR20004 is more effective than placebo in controlling blood glucose in patients with type 2 diabetes. Evaluate the efficacy, safety, and pharmacokinetics of SHR20004 after 24 weeks of treatment.
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a new pill shrink tumors in EGFR-Mutant lung cancer?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of CFT8919 capsules in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) carrying EGFR mutations. The main questions it aims to answer a…
Phase 1 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection calm psoriatic arthritis?
Disease control OngoingThis study is a randomized, double-blind, multicenter, placebo-controlled Phase III clinical study, consisting of a 4-week screening period, a 24-week core treatment period, a 24-week maintenance treatment period, and an 8-week safety follow-up period. It is planned to include 15…
Phase 3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Heat therapy aims to burn away cervical precancer
Disease control By invitation onlyHuman papillomavirus(HPV) infect epithelial cells and have the capacity to stimulate cell abnormal hyperplasia, especially by those high-risk HPV types. HPV vaccine primarily targeting HPV6/11/16/18 has been available and makes it possible to prevent cervical cancer. However, a l…
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a steroid shot into the windpipe protect preemies' lungs?
Prevention CompletedThe goal of this clinical trial is to learn if budesonide works to prevent bronchopulmonary dysplasia in newborn less than 32 weeks gestational age or birth weight less than 1500 g with respiratory distress syndrome who needs surfactants. Does budesonide lower the incidence of br…
Phase 4 • Sponsor: Indonesia University • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
Could a diabetes pill save kidneys? new trial aims to find out
Disease control Recruiting nowPowerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remai…
Phase 3 • Sponsor: Alessandro Doria • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a new weekly shot beat semaglutide for diabetes control?
Disease control CompletedThe study is being conducted to evaluate the efficacy and safety of HRS9531 once weekly (QW) in subjects with type 2 diabetes mellitus not adequately controlled with metformin monotherapy or in combination with SGLT2 inhibitors compared to Semaglutide QW for 36 weeks and 52 weeks…
Phase 3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can an extra stent stop a torn aorta from growing?
Disease control Recruiting nowThis clinical trial is a prospective, multicenter, open label study designed to evaluate the effectiveness and the safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection in patients eligible for thoracic endovascular aortic repair with …
Sponsor: Intressa Vascular SA • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a new pill tame blood pressure that Won't budge?
Disease control CompletedThis is a Phase II, multicentre, randomised, double-blinded, placebo-controlled, parallel group study to evaluate the safety, and effect of low, middle and high dose of SAL0120 versus placebo, administered once daily (QD) orally, on the reduction of systolic blood pressure in app…
Phase 3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a Clot-Removing device shield the Brain's thinking power after stroke?
Disease control Recruiting nowThe objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.
Sponsor: Rapid Medical • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug aims to strengthen bones in kids with rare brittle bone disease
Disease control OngoingThe primary objective of the study is to evaluate the effect of setrusumab on reduction in fracture rate, including morphometric vertebral fractures.
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Light therapy inside the body: a new hope for chronic pelvic pain?
Symptom relief CompletedThe goal of this clinical study is to determine if 8 treatments with photobiomodulation using near-infrared laser energy can help reduce chronic pelvic pain in women. Additionally, researchers want to determine if treatment with this type of energy can also alleviate pain with ac…
Phase 2 • Sponsor: SoLa Pelvic Therapy • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can a targeted drug trio tame a rare amyloid disease?
Disease control OngoingVenetoclax is considered as a promising agent for light-chain (AL) amyloidosis due to the high percentage of t(11;14). Several retrospective studies showed venetoclax-based therapy could induce rapid and profound hematologic response in AL patients with favorable safety profile. …
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC